virology
422 проекта
FP6Реинтеграция2005–2006Гърция
HIV-1 PHYLOGENY · Assessment of the accuracy of different phylogenetic methods for HIV-1 contact tracing and HIV-1 molecular epidemiology in Greece
FP6Реинтеграция2005–2006Полша
MOLECULARCLOCK TOOLS · Development of tools for the analysis of molecular clock and their application for a case of Hepatitis C Virus epidemics with known infection history
FP6Индивидуална стипендия2005–2007Обединеното кралство
I.S.Q.C. · Improving seed quality in cereals by manipulating gene expression and partitioning
FP6Индивидуална стипендия2005–2007Франция
CROSS PRESENTATION · Antigen presentation and T cell-mediated immunity: membrane trafficking in cross-presentation
FP6Индивидуална стипендия2005–2007Франция
RNA CUREPPR · RNA interference as a potential control of peste des petits ruminants
FP6Друго2005–2007Ирландия
VIRAL IMMUNE EVASION · Using viral inhibitors to characterise signalling pathways involved in interferon induction
FP6Индивидуална стипендия2005–2006Обединеното кралство
PLANTIRABIES · GENERATION OF NEW ANTI-RABIES ANTIBODIES FOR POST EXPOSURE PROPHYLAXIS AND PRODUCTION IN PLANTS.
FP6Реинтеграция2005–2005Полша
MBLUKP · Clinical consequences of mannose binding lectin dysfunction.
FP6Индивидуална стипендия2004–2006Норвегия
CLM RECEPTOR FAMILY · CMRF35-like molecules: a novel receptor family involved in the control of myeloid cell function
FP6Реинтеграция2004–2005Германия
PML NUCLEAR BODIES · Function and regulation of promyelocytic leukemia (PML) nuclear bodies (NB) and their role in innate immunity and antiviral resistance
FP6Индивидуална стипендия2004–2007Нидерландия
PKCEPSILON AND ALCOHOL · Amygdala CRF in reduced anxiety and alcohol consumption in PKCepsilon null mice
FP6Индивидуална стипендия2004–2005Обединеното кралство
MEASURE RISK! · The Validity of Different Survey Methods to Measure Risk Behaviour for Hiv the Sti - Comparison of Self-Reports the Biomedical Data
FP6Индивидуална стипендия2004–2006Италия
ELEUTHESYNTHESIS · Synthesis of Eleutheside Analogues : Potential Microtubule-Stabilizing Anticancer Drugs
FP6Индивидуална стипендия2004–2005Нидерландия
J.A. RODRIGUEZ-FEO · Role of caveosome-medicated endocytosis during MMP-2 activation
FP6Индивидуална стипендия2004–2006Германия
HBVENTRYVISUALISED · Visualisation of the early steps of human hepatitis B virus infection: a colourful approach
FP5Индивидуална стипендия2003–2004Германия
XANDER DE HAAN · The use of vaccinia virus infection as a model system to study interactions between the endoplasmic reticulum and microtubules
FP5Докторантска мрежа2002–2006Франция
SDO · Silencing in different organisms
6 партньори · 5 държави
FP5Обучителен център2002–2006Нидерландия
DC-TARGETING · Developing tumor vaccines, that utilise bodies own immune system, through dc targeting.
FP5Обучителен център2002–2006Белгия
Theoretical research on charge correlation in low dimensional systems
FP5Обучителен център2002–2006Словения
Pt (ii) and pd (ii) complexes with oligonucleotides and dna constituents as virus inhibitors
FP5Индивидуална стипендия2001–2003Обединеното кралство
Localisation, dynamics and regulation of herpes simplex virus type 1 genomes in lytic and quiescent infection
FP5Индивидуална стипендия2000–2001Италия
TSWV · Immunotherapy for plant protection against tomato spotted wilt virus (TSWV)
FP5Индивидуална стипендия2000–2002Германия
Vaccinia virus, a model system to study microtubule motors and centrosome fuction.
FP4Индивидуална стипендия1998–2001Нидерландия